EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH

Yang Liu, Chenbei Yao, Bin Sheng, Simin Zhi, Xiangxin Chen, Pengfei Ding, Jiatong Zhang, Zhennan Tao, Wei Li, Zong Zhuang, Jiannan Mao, Zheng Peng und 2 weitere

Translational Stroke Research · 2025

DOI: 10.1007/s12975-023-01228-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2025. Verfasst von Yang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China. Hauptthemen laut MEDLINE: Mitophagy, Ubiquitin-Protein Ligases, GTP Phosphohydrolases, Subarachnoid Hemorrhage. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Special Fund of Drum Tower Hospital Clinical Research, Nanjing Health Science and Technology Development Special Funds Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subarachnoid hemorrhage (SAH) is a type of stroke with a high disability and mortality rate. Apoptosis caused by massive damage to mitochondria in neuron cells and inflammatory responses caused by high extracellular ATP lead to poor outcomes. USP30 is a deubiquitinating enzyme that inhibits mitophagy, resulting in a failure to remove damaged mitochondria in a timely manner after SAH; nevertheless, the pathway through which USP30 inhibits mitophagy is unknown. This study evaluated the neuroprotective role and possible molecular basis by which inhibiting USP30 to attenuate SAH-induced EBI by promoting neuronal mitophagy. We used an in vitro model of hemoglobin exposure and an in vivo model of intravascular perforation. Increased expression of USP30 was found after SAH in vivo and in vitro, and USP30 inhibition expression in SAH mice treated with MF094 resulted in significant improvement of neurological injury and inflammatory response and mediated good outcomes, suggesting a neuroprotective effect of USP30 inhibition. In cultured neurons, inhibition of USP30 promoted ubiquitination modification of mitochondrial fusion protein 2 (MFN2) by E3 ubiquitin ligase (Parkin), separating damaged mitochondria from the healthy mitochondrial network and prompting mitophagy, causing early clearance of damaged intracellular mitochondria, and reducing the onset of apoptosis. The high extracellular ATP environment was meliorated, reversing the conversion of microglia to a pro-inflammatory phenotype and reducing inflammatory injury. USP30 inhibition had no autophagy-promoting effect on structurally and functionally sound mitochondria and did not inhibit normal intracellular ATP production. The findings suggest that USP30 inhibition has a neuroprotective effect after SAH by promoting early mitophagy after SAH to clear damaged mitochondria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyUbiquitin-Protein LigasesGTP PhosphohydrolasesSubarachnoid HemorrhageBrain InjuriesMitochondrial ProteinsThiolester HydrolasesAnimalsUbiquitinationMiceMaleMice, Inbred C57BLNeuronsMitochondriaPyrrolesPyrrolidines

Stichwörter der Autor:innen

MF094Mitochondrial fusion protein 2 (MFN2)MitophagySubarachnoid hemorrhage (SAH)Ubiquitin-specific protease 30 (USP30)Ubiquitination

Substanzen

parkin proteinUbiquitin-Protein LigasesGTP PhosphohydrolasesMfn2 protein, mouseMitochondrial ProteinsThiolester Hydrolases1-(1-(4-fluorophenyl)-2,5-dimethylpyrrol-3-yl)-2-pyrrolidin-1-ylethanonePyrrolesPyrrolidines

Autor:innen und Institutionen

  • Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu, China. yanhuiying8888@126.com.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, Jiangsu, China. njneurosurgery@163.com.
  • Department of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, Jiangsu, China. njneurosurgery@163.com.

Förderung

  • National Natural Science Foundation of China
  • Special Fund of Drum Tower Hospital Clinical Research
  • Nanjing Health Science and Technology Development Special Funds Project

Zitieren

APA

Liu, Y., Yao, C., Sheng, B., Zhi, S., Chen, X., Ding, P., Zhang, J., Tao, Z., Li, W., Zhuang, Z., Mao, J., Peng, Z., Yan, H., & Jin, W. (2025). Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH. Translational Stroke Research. https://doi.org/10.1007/s12975-023-01228-3

Vancouver

Liu Y, Yao C, Sheng B, Zhi S, Chen X, Ding P, et al. Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH. Translational Stroke Research. 2025. doi:10.1007/s12975-023-01228-3

BibTeX
@article{Liu2025,
  author = {Liu, Yang and Yao, Chenbei and Sheng, Bin and Zhi, Simin and Chen, Xiangxin and Ding, Pengfei and Zhang, Jiatong and Tao, Zhennan and Li, Wei and Zhuang, Zong and Mao, Jiannan and Peng, Zheng and Yan, Huiying and Jin, Wei},
  title = {Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH},
  journal = {Translational Stroke Research},
  year = {2025},
  doi = {10.1007/s12975-023-01228-3}
}
Kostenlos starten →